Why the Karnataka High Court’s Stay of FSSAI Advisory and AYUSH Directive on Ashwagandha Leaves Raises Significant Questions of Statutory Authority, Natural Justice, and Constituti

The Karnataka High Court, exercising its inherent jurisdiction to supervise the legality of administrative measures, issued an order staying the Food Safety and Standards Authority of India advisory that sought to impose restrictions on the commercial and medicinal use of ashwagandha leaves. In a concurrent development, the same court also stayed a directive issued by the Ministry of AYUSH, which similarly endeavored to curtail the utilization of ashwagandha leaves in traditional and contemporary therapeutic practices across the state of Karnataka. The stay order therefore preserves the status quo, allowing manufacturers, practitioners, and consumers to continue employing ashwagandha leaves without interference from the contested advisory and directive while the parties seek clarification on the statutory basis and procedural propriety of the imposed restrictions. By intervening, the High Court invites scrutiny of the respective regulatory frameworks governing food safety and traditional medicine, raising questions concerning the scope of delegated legislative power, the requirement of reasoned decision‑making, and the observance of natural justice principles in the formulation of health‑related advisories and directives. Consequently, the judicial intervention not only suspends the immediate regulatory impact on ashwagandha leaf usage but also sets the stage for a comprehensive legal assessment of whether the advisory and the directive were issued within the confines of the enabling statutes, complied with procedural fairness, and respected the constitutional right to liberty and livelihood of those engaged in the cultivation, processing, and therapeutic application of the herb.

One primary question is whether the Food Safety and Standards Authority of India and the Ministry of AYUSH possess the statutory competence to promulgate an advisory and a directive that categorically restrict the use of ashwagandha leaves in commercial and therapeutic contexts. The answer may depend on the respective enabling statutes, such as the Food Safety and Standards Act and the Ayurvedic, Siddha and Unani Drugs (ASU) Act, which delineate the scope of regulatory powers and the procedural requisites for imposing restrictions that affect trade and health practices. If the statutes grant only advisory functions without binding effect, the imposition of a de facto prohibition may be viewed as exceeding delegated authority, thereby rendering the measures vulnerable to judicial invalidation.

Another pressing question is whether the affected manufacturers, practitioners, and consumers were afforded a reasonable opportunity to be heard before the advisory and directive were finalized, invoking the audi alteram partem principle that underpins natural justice in Indian administrative law. The answer may turn on whether the regulatory agencies conducted a formal consultation process, published draft guidelines for comment, or merely issued the restrictions unilaterally, as the presence or absence of such procedural safeguards directly influences the validity of the intervention under the Administrative Tribunals Act and related jurisprudence. Absent demonstrable compliance with procedural due process, a court may deem the stay as a necessary protective measure to preserve the status quo pending a full adjudication of the procedural adequacy of the advisory and directive.

A further question concerns the constitutional dimension, specifically whether the blanket restriction on ashwagandha leaves infringes the fundamental right to practice any profession, or the right to livelihood, as enshrined in Article 19(1)(g) of the Constitution, when the restriction is not demonstrably necessary to protect public health. The answer may rely on the proportionality test, requiring the state to show that the restriction is a rational means to achieve a legitimate objective, is the least restrictive alternative, and maintains a fair balance between individual freedoms and collective welfare. If the judiciary determines that the advisory and directive lack a demonstrable nexus to a pressing public‑health concern, the stay may be upheld as a safeguard of constitutional freedoms pending a more narrowly tailored regulatory framework.

Finally, one may ask how the standards of judicial review applied by the Karnataka High Court in granting the stay will shape future interactions between health regulators and the private sector, particularly whether the court will impose a duty to undertake a reasoned impact assessment before imposing comparable restrictions. The answer may rest on precedents that require administrative actions to be transparent, evidence‑based, and proportionate, suggesting that the stay could compel the regulators to publish a detailed justification and to entertain objections before any future advisory or directive becomes operative. Should the regulators respond by revising the measures to incorporate stakeholder feedback and empirical risk data, the courts may lift the stay, whereas a refusal to align with procedural and constitutional norms could result in a prolonged injunction and potential liability for arbitrary administrative action.